Concepedia

Annick Mühlethaler‐Mottet

AM

Statistics

Publications

32

Citations

3.6K

H-Index

25

Active since

1994

Affiliations

University Hospital of Lausanne(Current)

University of Geneva

University of Lausanne

Institut Gustave Roussy

Inserm

Annick Mühlethaler‐Mottet is an author at University Hospital of Lausanne specializing in oncology, life sciences, and neuroblastoma biology.

ORCID

Publications per year

1994–2022

32

Publications

32

Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITA

Viktor Steimle, Claire-Anne Siegrist, Annick Mühlethaler‐Mottet et al. · Science · 1994 · 899 citations

, , +16

Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA

Annick Mühlethaler‐Mottet, L. Otten, Viktor Steimle et al. · The EMBO Journal · 1997 · 503 citations

, , +17

Activation of the MHC Class II Transactivator CIITA by Interferon-γ Requires Cooperative Interaction between Stat1 and USF-1

Annick Mühlethaler‐Mottet, Wilma Di Berardino, L. Otten et al. · Immunity · 1998 · 375 citations · Full text

, , +14

CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex

Krzysztof Masternak, Annick Mühlethaler‐Mottet, Jean Villard et al. · Genes & Development · 2000 · 351 citations · Full text

, , +15

The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway

Marjorie Flahaut, Roland Meier, Aurélie Coulon et al. · Oncogene · 2009 · 199 citations

, , +13

1–5 of 32